Related Articles
HER2/neu-derived peptides recognized by both cellular and humoral immune systems in HLA-A2+ cancer patients
Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex® technology
Cox-2 and Her2/neu co-expression in invasive bladder cancer
HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma